Neurology

Migraine prevention guidelines elevate CGRP drugs after a 14-year gap

After 14 years without a revision, US neurologists and headache specialists have folded CGRP-targeted drugs into the front rank of migraine prevention. That changes the first conversation in the clinic and the coverage fight behind it.